Programmed cell death protein-1 (PD1) expression in the microenvironment of classical Hodgkin lymphoma is similar between favorable and adverse outcome and does not enrich over serial relapses with conventional chemotherapy

• Joseph G. Taylor,
• Andrew Clear,
• Maria Calaminici,
• John G. Gribben

Affiliations

Joseph G. Taylor

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London;Department of Haemato-Oncology, St. Bartholomew’s Hospital, London

Andrew Clear

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London

Maria Calaminici

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London;Department of Histopathology, Royal London Hospital, UK

John G. Gribben

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London;Department of Haemato-Oncology, St. Bartholomew’s Hospital, London